RecruitingPhase 2NCT07589595
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Sponsor: Eli Lilly and Company
Golden Valley, MN · Rochester, MN · +40 more sites
6 recruiting alzheimer's disease studies with a site in Rochester, MN.
All trials in Rochester, MN · All Alzheimer's Disease trials
Sponsor: Eli Lilly and Company
Golden Valley, MN · Rochester, MN · +40 more sites
Sponsor: Eidos Therapeutics, a BridgeBio company
Rochester, MN · +39 more sites
Sponsor: Mayo Clinic
Rochester, MN
Sponsor: Mayo Clinic
Rochester, MN
Sponsor: Mayo Clinic
Rochester, MN · +1 more sites
Sponsor: University of Calgary
Rochester, MN · +1 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.